Peter Hersey

Biography

 Professor Hersey is a graduate in medicine from the University of Adelaide and in science from the University of Oxford where he completed a D.Phil in tumor immunology. He has worked closely with the Sydney and Newcastle Melanoma Units on Immunological aspects of melanoma and has been the principal investigator for a randomized trial of adjuvant immunotherapy in Stage 11b,111 melanoma and several trials of dendritic cell vaccines in patients with stage IV melanoma. He is Professor of Melanoma Biology at the University of Sydney, Research Director of the Newcastle Melanoma Unit and Consultant Immunologist to the Melanoma Institute Australia. He is a Member of the International working group on Melanoma and the Global melanoma task force. He has contributed extensively to studies on sensitivity of melanoma cells to apoptosis induced by the immune system and chemotherapy and treatments which sensitize melanoma to therapy. He holds the view that overcoming resistance to cell death pathways in melanoma holds the key to advances in treatment of melanoma. He is joint holder of a National Health and Medical Research Council Program grant for studies on melanoma. He is on the editorial board of a number of international journals and has contributed extensively to melanoma research. Dr Hersey is author of over 260 papers on original research related to melanoma.

Research Interest

 Surgery